Vaccins contenant une particule pseudo-virale comportant un oligonucléotide spécifique cpg et lerus utilisations

Specific virus-like particle-cpg oligonucleotide vaccines and uses thereof

Abstract

L'invention concerne des vaccins contenant, pour seul principe actif, une particule pseudo-virale comportant un oligonucléotide spécifique CpG fixé et un support ou diluant pharmaceutiquement acceptable non toxique, et leurs utilisations. L'invention concerne également une composition pharmaceutique comprenant un vaccin constitué d'une particule pseudo-virale comportant un oligonucléotide spécifique CpG, un ou plusieurs supports ou diluants pharmaceutiquement acceptables non toxiques, et un mélange d'agents thérapeutiques, et ses utilisations.
The invention provides vaccines containing, as its only active ingredient, a VLP having a CpG oligonucleotide attached thereto and a non-toxic pharmaceutically acceptable carrier or diluent and uses thereof. The invention further provides a pharmaceutical composition comprising a vaccine consisting of a VLP having a CpG oligonucleotide, one or more non-toxic pharmaceutically acceptable carrier or diluent, and a therapeutic agent admixture therewith and uses thereof.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (5)

    Publication numberPublication dateAssigneeTitle
    US-2006240024-A1October 26, 2006The Johns Hopkins University, St Jude Children's Research Hospital Inc.T cell regulation
    US-2006251677-A1November 09, 2006Cytos Biotechnology AgPackaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
    US-2009263405-A1October 22, 2009Government Of The United States Of America Represented By The SecretaryCpG OLIGONUCLEOTIDE PRODRUGS, COMPOSITIONS THEREOF AND ASSOCIATED THERAPEUTIC METHODS
    US-2010061936-A1March 11, 2010Kui ShenUnnatural amino acids capable of covalently modifying protein phosphatases and their use as general and specific inhibitors and probes
    WO-2013116656-A1August 08, 2013Emory UniversityImmunostimulatory compositions, particles, and uses related thereto

NO-Patent Citations (0)

    Title

Cited By (0)

    Publication numberPublication dateAssigneeTitle